97 related articles for article (PubMed ID: 10482373)
1. Imaging of locally recurrent and metastatic thyroid cancer with positron emission tomography.
Conti PS; Durski JM; Bacqai F; Grafton ST; Singer PA
Thyroid; 1999 Aug; 9(8):797-804. PubMed ID: 10482373
[TBL] [Abstract][Full Text] [Related]
2. 2-Deoxy-2-[18F]fluoro-D-glucose-positron emission tomography and positron emission tomography/computed tomography diagnosis of patients with recurrent papillary thyroid cancer.
Iagaru A; Masamed R; Singer PA; Conti PS
Mol Imaging Biol; 2006; 8(5):309-14. PubMed ID: 16758370
[TBL] [Abstract][Full Text] [Related]
3. The role of 18F-FDG PET/CT in detecting metastatic deposits of recurrent medullary thyroid carcinoma: a prospective study.
Rubello D; Rampin L; Nanni C; Banti E; Ferdeghini M; Fanti S; Al-Nahhas A; Gross MD
Eur J Surg Oncol; 2008 May; 34(5):581-6. PubMed ID: 17892923
[TBL] [Abstract][Full Text] [Related]
4. The role of positron emission tomography/computed tomography in the management of recurrent papillary thyroid carcinoma.
Nahas Z; Goldenberg D; Fakhry C; Ewertz M; Zeiger M; Ladenson PW; Wahl R; Tufano RP
Laryngoscope; 2005 Feb; 115(2):237-43. PubMed ID: 15689742
[TBL] [Abstract][Full Text] [Related]
5. Focal uptake of (18)F-fluorodeoxyglucose by thyroid in patients with nonthyroidal head and neck cancers.
Nam SY; Roh JL; Kim JS; Lee JH; Choi SH; Kim SY
Clin Endocrinol (Oxf); 2007 Jul; 67(1):135-9. PubMed ID: 17465995
[TBL] [Abstract][Full Text] [Related]
6. F-18 FDG PET detection of a medullary thyroid carcinoma in a patient with metastatic colonic cancer; literature review.
Cohen R; Bihan H; des Guetz G; Wind P; Martin A
Ann Endocrinol (Paris); 2009 Dec; 70(6):468-72. PubMed ID: 19744643
[TBL] [Abstract][Full Text] [Related]
7. ¹⁸F-FDG-PET and ¹⁸F-FDG-PET/CT in the detection of recurrent or metastatic medullary thyroid carcinoma: a systematic review and meta-analysis.
Cheng X; Bao L; Xu Z; Li D; Wang J; Li Y
J Med Imaging Radiat Oncol; 2012 Apr; 56(2):136-42. PubMed ID: 22498184
[TBL] [Abstract][Full Text] [Related]
8. Positron emission imaging of head and neck cancer, including thyroid carcinoma.
Schöder H; Yeung HW
Semin Nucl Med; 2004 Jul; 34(3):180-97. PubMed ID: 15202100
[TBL] [Abstract][Full Text] [Related]
9. [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography localizes residual thyroid cancer in patients with negative diagnostic (131)I whole body scans and elevated serum thyroglobulin levels.
Wang W; Macapinlac H; Larson SM; Yeh SD; Akhurst T; Finn RD; Rosai J; Robbins RJ
J Clin Endocrinol Metab; 1999 Jul; 84(7):2291-302. PubMed ID: 10404792
[TBL] [Abstract][Full Text] [Related]
10. FDG-PET in head and neck, and thyroid cancer.
Macapinlac HA
Chang Gung Med J; 2005 May; 28(5):284-95. PubMed ID: 16086543
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography in the follow-up of papillary or follicular thyroid cancer.
Hooft L; Hoekstra OS; Devillé W; Lips P; Teule GJ; Boers M; van Tulder MW
J Clin Endocrinol Metab; 2001 Aug; 86(8):3779-86. PubMed ID: 11502811
[TBL] [Abstract][Full Text] [Related]
12. Combined positron emission tomography/computed tomography imaging of recurrent thyroid cancer.
Zimmer LA; McCook B; Meltzer C; Fukui M; Bascom D; Snyderman C; Townsend DW; Johnson JT
Otolaryngol Head Neck Surg; 2003 Feb; 128(2):178-84. PubMed ID: 12601311
[TBL] [Abstract][Full Text] [Related]
13. The use of imaging studies in the diagnosis and management of thyroid cancer and hyperparathyroidism.
James C; Starks M; MacGillivray DC; White J
Surg Oncol Clin N Am; 1999 Jan; 8(1):145-69. PubMed ID: 9824366
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors affecting disease-specific survival in patients with recurrent and/or metastatic differentiated thyroid carcinoma detected by positron emission tomography/computed tomography.
Akkas BE; Demirel BB; Vural GU
Thyroid; 2014 Feb; 24(2):287-95. PubMed ID: 23750862
[TBL] [Abstract][Full Text] [Related]
15. Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.
Chang HT; Hu C; Chiu YL; Peng NJ; Liu RS
PLoS One; 2014; 9(12):e115127. PubMed ID: 25517451
[TBL] [Abstract][Full Text] [Related]
16. Potential role of fluorine-18-deoxyglucose (FDG) positron emission tomography (PET) in the staging of primitive and recurrent medullary thyroid carcinoma.
Gasparoni P; Rubello D; Ferlin G
J Endocrinol Invest; 1997 Oct; 20(9):527-30. PubMed ID: 9413806
[TBL] [Abstract][Full Text] [Related]
17. ¹⁸F-FDG and new positron emitter radiotracers for detecting recurrent medullary thyroid carcinoma.
Marzola MC; Rubello D
J Med Imaging Radiat Oncol; 2012 Apr; 56(2):132-5. PubMed ID: 22498183
[No Abstract] [Full Text] [Related]
18. The prognostic value of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in patients with suspected residual or recurrent medullary thyroid carcinoma.
Bogsrud TV; Karantanis D; Nathan MA; Mullan BP; Wiseman GA; Kasperbauer JL; Reading CC; Björo T; Hay ID; Lowe VJ
Mol Imaging Biol; 2010 Oct; 12(5):547-53. PubMed ID: 19949985
[TBL] [Abstract][Full Text] [Related]
19. The value of positron emission tomography (PET) in the management of patients with thyroid cancer.
Robbins RJ; Larson SM
Best Pract Res Clin Endocrinol Metab; 2008 Dec; 22(6):1047-59. PubMed ID: 19041831
[TBL] [Abstract][Full Text] [Related]
20. Clinical usefulness of positron emission tomography-computed tomography in recurrent thyroid carcinoma.
Razfar A; Branstetter BF; Christopoulos A; Lebeau SO; Hodak SP; Heron DE; Escott EJ; Ferris RL
Arch Otolaryngol Head Neck Surg; 2010 Feb; 136(2):120-5. PubMed ID: 20157055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
